Cite
HARVARD Citation
De Miguel Buckley, R. et al. (2022). Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance. Open forum infectious diseases. p. . [Online].